## Note
nid: 1496864694059
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::!FLAG_THESE_CARDS::!DELETE, #AK_Step1_v11::#B&B::11_Hematology::04_Cancer_Drugs::06_Other_Cancer_Drugs, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::Cetuximab, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::21_Cetuximab_Panitumumab, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#Physeo::09_Pharm::17_Hem/Onc_Pharm::Rituximab_Bevacizumab_Alemtuzumab_Cetuximab_Panitumumab_Trastuzmab, #AK_Step1_v11::#Pixorize::02_Biochem::22_Onc_Drugs::03_Cetuximab,_Panitumumab, #AK_Step1_v11::#Pixorize::03_Pharm::11_Oncology::Cetuximab,_Panitumumab, #AK_Step1_v11::#SketchyPharm::08_Antineoplastics::03_Kinase_Inhibitors_&_Monoclonal_Antibodies::02_Rituximab,_cetuximab,_bevacizumab,_alemtuzumab,_trastuzumab::zanki_extra, #AK_Step1_v11::^Other::^EXPN, #AK_Step1_v11::^Other::^FA_Updates::FA2019, #AK_Step1_v11::^Other::^HighYield::2-RelativelyHighYield
markdown: false

### Text
<div>
  <div>
    Because the skin has abundant <b>EGFR</b>, patients undergoing
    <b>Cetuximab</b> treatment can experience a(n)
    {{c1::<b>Papulopustular acneiform}} rash</b>
  </div>
</div>

### Extra
FA 2019: also lists <b>panitumumab</b>
<div><img src="paste-48576080117761.jpg"></div>
<div><img src="paste-45857365819393.jpg"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="paste-34286723923971.jpg"><img src=
"paste-34359738368003.jpg"><img src=
"paste-34398393073667.jpg"><img src="paste-34540126994435.jpg">

### Sketchy
<img src="paste-390537081257985.jpg" class="resizer"><img src=
"paste-87d74ac95a67d78e1a0443bd770c17f44240fcf8.png" class=
"resizer">

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_4.png"></a>
</div>

### Additional Resources


### One by one

